Goto, Shinji

Dr Shinji Goto has been working on discovering drug targets for calcific aortic valve disease at CICS since 2015.
Before joining CICS, he researched the development of a new PPARα agonist as a selective anti-hyperlipidemic drug at Tokyo New Drug Research Laboratories (Kowa Company, Ltd.). He received his Ph.D. in Pharmaceutical Science at Tohoku University in 2012. There, he studied cellular signaling mediated by thromboxane A2 receptor.